Skip to main content
Tanya Wilcox
( out of 78 reviews )

Tanya Wilcox, MD

Languages spoken: English

Clinical Locations

Primary Location

Cardiovascular Center

Cardiovascular Center
50 N Medical Dr
Salt Lake City , UT 84132

University of Utah Hospital

50 N Medical Dr
Salt Lake City , UT 84132

Dr. Tanya Wilcox completed her medical education at the University of California, Irvine following her undergraduate degree in evolutionary biology at Princeton. She continued her medical training with a residency and chief residency in internal medicine followed by a fellowship in cardiovascular diseases at New York University.

Dr. Wilcox is a general cardiologist with clinical expertise in preventative cardiology, lipidology, disorders of metabolism, and echocardiography. Her academic interests include investigating the association between metabolic risk factors and cardiovascular disease and perioperative cardiovascular outcomes. She is also interested in medical education and is involved in teaching medical students, residents, and fellows.

Dr. Wilcox is board certified in internal medicine, cardiovascular diseases and echocardiography. She is also a board certified lipid specialist.

Specialties

Board Certification

American Board of Internal Medicine (Internal Medicine)
American Board of Clinical Lipidology
National Board of Medical Examiners

Patient Rating

4.9 /5
( out of 78 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

The scale on which responses are measured is 1 to 5 with 5 being the best score.

Patient Comments

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

2026-01-25
UNIVERSITY HOSPITAL

Dr. Wilcox is very knowledgeable and thorough. She answers all of my questions in a kind and patient manner.

2026-01-12
UNIVERSITY HOSPITAL

Dr. Wilcox is easy to talk to and she answers the questions that I had. She is personable and caring.

2025-12-17
UNIVERSITY HOSPITAL

Let's clone Dr Wilcox. She is at once competent, professional and warm. What an asset to the University!

2025-11-22
UNIVERSITY HOSPITAL

She was very good

2025-11-21
UNIVERSITY HOSPITAL

Very knowledgeable and up to date on Cardiology. Extremely fortunate to have her as my cardiologist.

2025-11-20
UNIVERSITY HOSPITAL

Dr Wilcox was thorough in reviewing my medical file. She addressed all necessary and vital concerns. She was very concerned about my health and medical condition.

2025-11-20
UNIVERSITY HOSPITAL

Dr Wilcox is way too intelligent for as young as she is: good training and good attitude pays off again.

2025-10-19
UNIVERSITY HOSPITAL

Appreciative of her efforts to reach out to and work with the Aortic Dissection team. Felt comfortable that with Dr. Hirsch, Dr. Wilcox, my new primary and the Aortic Dissection team/ Vascular surgery team, I'm getting about as good care as possible. I'm grateful for everyone working together.

2025-10-19
UNIVERSITY HOSPITAL

Was only with her for a few minutes, but was very pleased.

Dr. Tanya Wilcox completed her medical education at the University of California, Irvine following her undergraduate degree in evolutionary biology at Princeton. She continued her medical training with a residency and chief residency in internal medicine followed by a fellowship in cardiovascular diseases at New York University.

Dr. Wilcox is a general cardiologist with clinical expertise in preventative cardiology, lipidology, disorders of metabolism, and echocardiography. Her academic interests include investigating the association between metabolic risk factors and cardiovascular disease and perioperative cardiovascular outcomes. She is also interested in medical education and is involved in teaching medical students, residents, and fellows.

Dr. Wilcox is board certified in internal medicine, cardiovascular diseases and echocardiography. She is also a board certified lipid specialist.

Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor (Clinical)
Radiology & Imaging Sciences -Adjunct Assistant Professor
Academic Divisions Cardiovascular Medicine
Board Certification
American Board of Internal Medicine (Internal Medicine)
American Board of Clinical Lipidology
National Board of Medical Examiners

Education history

Undergraduate Ecology and Evolutionary Biology - Princeton University B.A.
Professional Medical Medicine - University of California, Irvine School of Medicine M.D.
Certification Clinical Research Methods - New York University Clinical and Translational Science Institute Certificate
Internship Internal Medicine - New York University Grossman School of Medicine Intern
Residency Internal Medicine - New York University Grossman School of Medicine Resident
Chief Resident Internal Medicine - New York University Grossman School of Medicine Chief Resident
Fellowship Cardiology - New York University Grossman School of Medicine Fellow

Selected Publications

Journal Article

  1. Wilcox T, Smilowitz NR, Seda B, Xia Y, Hochman J, Berger JS (2022). Sex Differences in Thrombosis and Mortality in Patients Hospitalized for COVID-19. Am J Cardiol, 170, 112-117.
  2. Wilcox T, Smilowitz NR, Xia Y, Beckman JA, Berger JS (2021). Cardiovascular Risk Factors and Perioperative Myocardial Infarction After Noncardiac Surgery. Can J Cardiol, 37(2), 224-231.
  3. Wilcox T, Smilowitz NR, Xia Y, Berger JS (2019). Cardiovascular Risk Scores to Predict Perioperative Stroke in Noncardiac Surgery. Stroke, 50(8), 2002-2006.
  4. Newman JD, Wilcox T, Smilowitz NR, Berger JS (2018). Influence of Diabetes on Trends in Perioperative Cardiovascular Events. Diabetes Care, 41(6), 1268-1274.
  5. Wilcox T, Newman JD, Maldonado TS, Rockman C, Berger JS (2018). Peripheral vascular disease risk in diabetic individuals without coronary heart disease. Atherosclerosis, 275, 419-425.
  6. Pitzer VE, Viboud C, Alonso WJ, Wilcox T, Metcalf CJ, Steiner CA, Haynes AK, Grenfell BT (2015). Environmental drivers of the spatiotemporal dynamics of respiratory syncytial virus in the United States. PLoS Pathog, 11(1), e1004591.
  7. Tran MH, Lin DM, Wilcox T, Schiro D, Cannesson M, Milliken J (2014). Effects of a multimodality blood conservation schema toward improvement of intraoperative hemoglobin levels and off-pump transfusions in coronary artery bypass graft surgery. Transfusion, 54(10 Pt 2), 2769-74.
  8. Sunseri M, Ahuja T, Wilcox T, Green D (2018). Acquired Coagulopathy and Hemorrhage Secondary to Subcutaneous Heparin Prophylaxis. Case Rep Hematol, 2018, 9501863.

Review

  1. Wilcox T, De Block C, Schwartzbard AZ, Newman JD (2020). Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar. [Review]. J Am Coll Cardiol, 75, (16), 1956-1974.
  2. Tran MH, Wilcox T, Tran PN (2020). Catheter-related right atrial thrombosis. [Review]. J Vasc Access, 21, (3), 300-307.

Case Report

  1. St John E, Carey JR, Wilcox T, Ryan J, Ramakrishna S, Daud A, Diaz-Robles D, Smith A, Cowan K, Wang (2025). Expanding the Patient Pool for Rilonacept. JACC. Case reports, 30(17), 103799.